HighVista Strategies’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $698K | Buy |
2,305
+94
| +4% | +$28.4K | 0.26% | 116 |
|
|
2025
Q1 | $732K | Hold |
2,211
| – | – | 0.28% | 119 |
|
|
2024
Q4 | $682K | Hold |
2,211
| – | – | 0.25% | 117 |
|
|
2024
Q3 | $469K | Sell |
2,211
-323
| -13% | -$68.5K | 0.16% | 133 |
|
|
2024
Q2 | $710K | Hold |
2,534
| – | – | 0.26% | 108 |
|
|
2024
Q1 | $677K | Buy |
2,534
+1,103
| +77% | +$295K | 0.24% | 108 |
|
|
2023
Q4 | $331K | Sell |
1,431
-1,614
| -53% | -$373K | 0.12% | 124 |
|
|
2023
Q3 | $445K | Buy |
3,045
+249
| +9% | +$36.4K | 0.21% | 120 |
|
|
2023
Q2 | $646K | Hold |
2,796
| – | – | 0.3% | 110 |
|
|
2023
Q1 | $677K | Buy |
+2,796
| New | +$677K | 0.55% | 63 |
|
|
2022
Q4 | – | Sell |
-9,527
| Closed | -$619K | – | 117 |
|
|
2022
Q3 | $619K | Buy |
9,527
+4,727
| +98% | +$307K | 0.35% | 74 |
|
|
2022
Q2 | $344K | Buy |
4,800
+275
| +6% | +$19.7K | 0.21% | 88 |
|
|
2022
Q1 | $444K | Buy |
+4,525
| New | +$444K | 0.28% | 76 |
|